Carregant...
Interleukin-6: a new therapeutic target in systemic sclerosis?
Interleukin-6 (IL-6) is a classic pro-inflammatory cytokine critical in mounting an effective immune response. It is secreted by a wide array of cell types; however, its effector cells are more restricted, owing to the fact that very few cells, except lymphocytes and hepatocytes, express the functio...
Guardat en:
| Publicat a: | Clin Transl Immunology |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4232056/ https://ncbi.nlm.nih.gov/pubmed/25505952 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cti.2013.2 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|